India · Delayed Price · Currency is INR Hemo Organic Statistics
Total Valuation
Hemo Organic has a market cap or net worth of INR 47.52 million. The enterprise value is 63.92 million.
| Market Cap | 47.52M |
| Enterprise Value | 63.92M |
Important Dates
The last earnings date was Wednesday, February 11, 2026.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hemo Organic has 3.47 million shares outstanding. The number of shares has decreased by -2.88% in one year.
| Current Share Class | 3.47M |
| Shares Outstanding | 3.47M |
| Shares Change (YoY) | -2.88% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 43.72% |
| Owned by Institutions (%) | 8.08% |
| Float | 1.87M |
Valuation Ratios
The trailing PE ratio is 46.39.
| PE Ratio | 46.39 |
| Forward PE | n/a |
| PS Ratio | 1.91 |
| PB Ratio | -17.73 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 62.06 |
| EV / Sales | 2.57 |
| EV / EBITDA | n/a |
| EV / EBIT | 178.55 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 358.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 2.01% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 2.33% |
| Revenue Per Employee | 4.98M |
| Profits Per Employee | 206,000 |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -673,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.77% in the last 52 weeks. The beta is -0.20, so Hemo Organic's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | +27.77% |
| 50-Day Moving Average | 16.35 |
| 200-Day Moving Average | 11.52 |
| Relative Strength Index (RSI) | 39.87 |
| Average Volume (20 Days) | 5,006 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hemo Organic had revenue of INR 24.88 million and earned 1.03 million in profits. Earnings per share was 0.30.
| Revenue | 24.88M |
| Gross Profit | 2.87M |
| Operating Income | 358,000 |
| Pretax Income | 357,000 |
| Net Income | 1.03M |
| EBITDA | n/a |
| EBIT | 358,000 |
| Earnings Per Share (EPS) | 0.30 |
Balance Sheet
The company has 5,000 in cash and 16.41 million in debt, with a net cash position of -16.40 million or -4.73 per share.
| Cash & Cash Equivalents | 5,000 |
| Total Debt | 16.41M |
| Net Cash | -16.40M |
| Net Cash Per Share | -4.73 |
| Equity (Book Value) | -2.68M |
| Book Value Per Share | -0.78 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 11.54%, with operating and profit margins of 1.44% and 4.14%.
| Gross Margin | 11.54% |
| Operating Margin | 1.44% |
| Pretax Margin | 1.43% |
| Profit Margin | 4.14% |
| EBITDA Margin | n/a |
| EBIT Margin | 1.44% |
| FCF Margin | n/a |
Dividends & Yields
Hemo Organic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.88% |
| Shareholder Yield | 2.88% |
| Earnings Yield | 2.17% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |